- Home
- SCYX vs HUIZ Comparison
SCYX vs HUIZ Comparison
Compare SCYX & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- HUIZ
- Stock Information
- Founded
- SCYX 1999
- HUIZ 2006
- Country
- SCYX United States
- HUIZ China
- Employees
- SCYX N/A
- HUIZ N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- HUIZ Specialty Insurers
- Sector
- SCYX Health Care
- HUIZ Finance
- Exchange
- SCYX Nasdaq
- HUIZ Nasdaq
- Market Cap
- SCYX 40.9M
- HUIZ 33.3M
- IPO Year
- SCYX 2014
- HUIZ 2020
- Fundamental
- Price
- SCYX $1.03
- HUIZ $2.62
- Analyst Decision
- SCYX Buy
- HUIZ
- Analyst Count
- SCYX 1
- HUIZ 0
- Target Price
- SCYX N/A
- HUIZ N/A
- AVG Volume (30 Days)
- SCYX 135.5K
- HUIZ 24.0K
- Earning Date
- SCYX 03-12-2025
- HUIZ 03-24-2025
- Dividend Yield
- SCYX N/A
- HUIZ N/A
- EPS Growth
- SCYX N/A
- HUIZ N/A
- EPS
- SCYX N/A
- HUIZ N/A
- Revenue
- SCYX $3,746,000.00
- HUIZ $171,105,205.00
- Revenue This Year
- SCYX $1,541.00
- HUIZ N/A
- Revenue Next Year
- SCYX $111.43
- HUIZ $10.46
- P/E Ratio
- SCYX N/A
- HUIZ N/A
- Revenue Growth
- SCYX N/A
- HUIZ 4.46
- 52 Week Low
- SCYX $0.82
- HUIZ $2.15
- 52 Week High
- SCYX $3.07
- HUIZ $10.58
- Technical
- Relative Strength Index (RSI)
- SCYX 50.55
- HUIZ 31.54
- Support Level
- SCYX $1.00
- HUIZ $2.61
- Resistance Level
- SCYX $1.06
- HUIZ $3.27
- Average True Range (ATR)
- SCYX 0.07
- HUIZ 0.19
- MACD
- SCYX 0.02
- HUIZ -0.08
- Stochastic Oscillator
- SCYX 63.30
- HUIZ 11.11
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.